/ Home / Product Center / APIs / Others /

Apixaban

Apixaban
CAS
503612-47-3
MF
C25H25N5O4
MW
459.5
Purity
98%
Melting point
235-238°C
Solubility
DMSO (Slightly, Heated), Methanol (Slightly)
Appearance
White to Off-White solid
Storage Temp
Refrigerator
Indication
Venous thromboembolic
Description

Eliquis (apixaban), a direct inhibitor of factor Xa (FXa), was approved by the European Commission on May 18, 2011 for prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery.